March 25, 2014

Mylan on Monday announced the U.S. District Court for the Northern District of West Virginia ruled in favor of upholding the validity of patents protecting Perforomist (formoterol fumarate) Inhalation Solution.

July 8, 2013

A chronic obstructive pulmonary disease and asthma drug made by Sunovion infringes Mylan's patents on a similar drug, a federal judge has ruled, Mylan said.

June 10, 2013

Anglo-Swedish drug maker AstraZeneca will pay up to $1.15 billion for a U.S. developer of drugs for respiratory diseases, AstraZeneca said Monday.

May 21, 2013

A federal appellate court has ruled in favor of Mylan in a case involving a drug for chronic obstructive pulmonary disease, the drug maker said.

November 14, 2010

Most patients with mild persistent asthma overuse a drug combination despite an apparent lack of...

June 23, 2010

The Food and Drug Administration has approved a new drug by Merck for treating asthma...

June 6, 2010

The class of drugs known as long-acting beta agonists can provide many benefits to patients...

May 10, 2010

Nearly one-third of patients with asthma are taking their medications in a way that puts...

February 24, 2010

Mylan had profits of $93.5 million in 2009, the generic drug maker announced Thursday in...

February 18, 2010

British drug maker GlaxoSmithKline issued a response to new labeling requirements proposed by the Food...

February 17, 2010

Drugs belonging to the class called long-acting beta agonists should never be used alone for...